Supplements In The News

Supplement combination reverses Alzheimer’s symptoms in dogs

Aged beagles suffer a decline in memory similar to the pre-Alzheimer’s stage in humans, and develop a build-up of beta-amyloid protein in their brains similar to that found in humans with Alzheimer’s Disease. Beta-amyloid deposits are thought to be responsible for much of the brain damage suffered by Alzheimer’s patients.

Folic acid finds a role in treating arthritis and preventing strokes

Many people with rheumatoid arthritis are treated with the drug methotrexate, but find the side effects unacceptable. British researchers are now proposing that folic acid supplements can reduce these side effects without compromising the effectiveness of methotrexate.

Fish oil supplements fly off the shelves

A BBC TV documentary that was aired in Britain in January caused a rush on fish oil supplements. The documentary showed that fish oil, when consumed during pregnancy, results in offspring that are smarter and better behaved.

Europeans’ right to use nutritional supplements is on the firing line

The European Union is generally considered to be an institution for preventing future wars in Europe, and for enhancing the economies of the participating countries. On the other hand, the EU is a massive bureaucratic machine that could well destroy a great deal of Europeans’ personal freedom. A case in point is the current fight over nutritional supplements. The EU bureaucracy, strongly under the influence of the medical cartel, has issued a directive to ban large numbers of nutritional supplements in 2005. Opponents of the EU’s directive are going to court to try to preserve the rights of individuals to choose their health products for themselves.

Alpha-Lipoic Acid, Curcumin, vitamins C and E — they all show anti-Alzheimer’s effects

Alzheimer’s Disease is much in the news nowadays, and will be more so in years to come. As luck would have it, certain readily available supplements are also in the news as anti-Alzheimer’s treatments. Even Vitamins C and E recently received attention when researchers at Johns Hopkins University showed that people who take sizable doses of both vitamins C and E have a reduced risk of developing Alzheimer’s Disease. (“Sizable doses” means about 1,000 IU/day of vitamin E and 500 mg/day or more of vitamin C.)


The Kava scare — just more governmental hot air

In November 2001 the German government claimed that Kava supplements (made from the roots of Piper methysticum) were linked to severe liver damage, and a few months later these supplements were banned in Germany. Governments of other countries soon issued warnings about Kava. The U.S. news industry, holding true to its sensationalist reputation, immediately ran countless scare-articles about the subject.


New support for glucosamine and other remedies for joint pain

Countless people with pain in the knees have found relief in glucosamine and chondroitin supplements. Yet medical studies have not consistently demonstrated these benefits under controlled conditions — some studies show benefits, others don’t. Some observers have implied that the earlier studies were sponsored by supplement producers and therefore were deliberately biased in favor of the supplements. Other observers suspect, on the contrary, that the studies showing no benefit were poorly conducted — perhaps deliberately, in order to discourage the use of supplements that cut into the profits of the pharmaceutical industry and physicians’ cartel.


Cinnamon supplementation for lowering cholesterol

Two recent research papers describe the effects of cinnamon supplements on blood cholesterol levels. In experiments with rats, dietary cinnamate (a component of cinnamon) reduced both the production of cholesterol and the ‘peroxidation’ of lipids. Lipid peroxidation is a process whereby unsaturated fats are converted to substances that damage other tissues and are thought to be responsible for some of the symptoms of such diseases as Alzheimer’s, cardiovascular disease, and certain cancers.


Acetyl-L-carnitine has impact on Alzheimer’s and macular degeneration

Acetyl-L-carnitine (ALC, also known as ALCAR) has seen a lot of news coverage recently because of its reported anti-aging effects. Researchers are now studying it as a treatment for a variety of age-related illnesses, among which are Alzheimer’s Disease and Macular Degeneration (loss of central visual acuity). Two recent research studies illustrate the progress and promise shown by ALC for these two medical problems.
To get our newsletter please enter your email address in the box below and press 'Subscribe' button.